Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus

Lancet

Volumn 350, Issue 9090, 1997, Pages 1505-1510

  Morris, Andrew D ^a   Boyle, Douglas I R ^a   McMahon, Alex D ^a   Greene, Stephen A ^a   MacDonald, Thomas M ^a   Newton, Ray W ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; DIABETIC KETOACIDOSIS; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KETOACIDOSIS; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0031590552     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)06234-X     Document Type: Article

References (26)

1. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
2. Reichard P, Nilsson B, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993; 329: 304-09.
3. Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood glucose control on late complications of diabetes mellitus. N Engl J Med 1993; 341: 1306-09.
4. Pound N, Sturrock NDC, Jeffcoate WJ. Age-related changes in glycated haemoglobin in patients with insulin-dependent diabetes mellitus. Diabetic Med 1996; 13: 510-13.
5. Gill GV, Alberti KGMM. The outcome of brittle diabetes - a follow up study of young female diabetic patients with recurrent ketoacidosis. BMJ 1991; 303: 285-86.
6. Steel JM. Such a nice girl. Lancet 1994; 344: 765-66.
7. Gill GV, Walford S, Alberti KGMM. Brittle diabetes - present concepts. Diabetologia 1985; 28: 579-89.
8. Gill GV, Lucas S, Kent LA. Prevalence and characteristics of brittle diabetes in Britain. QJM 1996; 89: 839-43.
9. Glasgow RE, McCaul KD, Schafer LC. Self-care behaviours and glycemic control in type I diabetes. J Chronic Dis 1987; 40: 399-412.
10. Cerkoney KA, Hart LK. The relationship between the health belief model and compliance of persons with diabetes mellitus. Diabetes Care 1980; 3: 594-98.
11. Schafer LC, McKaul KD, Glasgow RE. Supportive and nonsupportive family behavoiurs: relationships to adherence and metabolic control in persons with type I diabetes. Diabetes Care 1986; 9: 179-85.
12. Kurtz MS. Adherence to diabetes regimens: empirical status and clinical implications. Diabetes Education 1990; 16: 50-56.
13. Morris AD, Boyle DIR, MacAlpine R, et al. The Diabetes Audit and Research in Tayside Scotland (DARTS) Study: electronic record linkage to create a district diabetes register. BMJ 1997; 315: 524-28.
14. Leese GP, Newton RW, Jung RT, Haining W, Ellingford A. Screening for diabetic retinopathy in a widely spaced population using non-mydriatic fundus photography in a mobile unit. Diabetic Med 1992; 9: 459-62.
15. MacDonald TM, McDevitt DG. The Tayside medicines monitoring unit (MEMO). In: Strom BL, ed. Pharmacoepidemiology, 2nd edn. Chichester: Wiley, 1994: 245-55.
16. Conover WJ, Iman RL. Analysis of covariance using the rank transformation. Biometrics 1982; 38: 715-24.
17. McNabb WL. Adherence in diabetes: can we define it and can we measure it? Diabetes Care 1997; 29: 215-18.
18. Polonsky WH, Anderson BJ, Lohrer PA. Insulin omission in women with IDDM. Diabetes Care 1994; 17: 1178-83.
19. Dunger DB, Edge JA. Diabetes and the endocrine change of puberty. Pract Diabetes Int 1995; 12: 63-66.
20. Rodin GM, Johnson LE, Garfinkel PE, Daneman D, Kenshole AB. Eating disorders in female adolescents with insulin dependent diabetes. Int J Psych Med 1986; 16: 49-57.
21. Beardon PHG, Brown SV, McDevitt DG. Post-marketing surveillance: a follow-up study of morbidity associated with cimetidine using record linkage. Pharmaceut Medicine 1988; 3: 185-93.
22. Scobie IN, MacCuish AC, Barrie T, Green FD, Foulds WS. Serious retinopathy in a diabetic clinic: prevalence and therapeutic implications. Lancet 1981; ii: 521.
23. Thompson CJ, Cummings F, Chalmers J, Newton RW. Abnormal insulin treatment behaviour: a major cause of ketoacidosis in the young adult. Diabetic Med 1995; 12: 429-32.
24. DeFronzo RA, Matsuda M, Barrett EJ. Diabetic ketoacidosis: a combined metabolic, nephrologic approach to therapy. Endocrine Revs 1994; 2: 209-22.
25. Rydall AC, Rodin GM, Olmsted MP, Devenyi RG, Daneman D. Disordered eating behaviour and microvascular complications in young women with insulin-dependent diabetes mellitus. N Engl J Med 1997; 336: 1849-54.
26. Acerini CL, Patton CM, Savage MO, Kernell A, Westphal O, Dunger DB. Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus. Lancet 1997; 350: 1199-204.